Immuneering Presents Design and Methodology of Ongoing Phase 3 Trial
Immuneering presented the design and methodology of its ongoing Phase 3 MAPKEEPER 301 trial at the ESMO Congress.
Immuneering presented the design and methodology of its ongoing Phase 3 MAPKEEPER 301 trial at the ESMO Congress.